ISI
Ionis Pharmaceuticals Inc
29/100
Smart-money confidence
Below average interest
No standout activity across the feeds we track.
Stocks scoring 0–25 beat the S&P 500 39.9% of the time over the next three months, since 2015. How we measured this →
8
hedge funds
hold it · 3 added, 5 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Who's behind the signal
Every informed buyer we can see on ISI, across all three feeds.
Hedge funds · 8
ARK Invest (Cathie Wood)
Increased +4%
Renaissance Technologies
Increased +83%
Gotham Asset Mgmt (Greenblatt)
Increased +22%
Tweedy Browne
Decreased −21%
D.E. Shaw & Co
Decreased −31%
Millennium Management (Englander)
Decreased −72%
+2 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar.
IONIS PHARMACEUTICALS INC isn't in the top-10 model right now, but 8 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
8
Investors
0
New positions
3
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset
Pinch to zoom · drag sideways to move through time
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.3×
% of portfolio
0.1%
Position change
+4%
0.1% of ARK Invest's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+83%
0.1% of Renaissance Technologies's portfolio
Trust weight: 1.1×
% of portfolio
0.0%
Position change
+22%
0.0% of Gotham Asset Mgmt's portfolio
Trust weight: 1.2×
% of portfolio
6.5%
Position change
−21%
6.5% of Tweedy Browne's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−31%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−72%
0.0% of Millennium Management's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−75%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−23%
0.0% of AQR Capital Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to IONIS PHARMACEUTICALS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell IONIS PHARMACEUTICALS INC or any security.